Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Shares Outstanding of 51.35 million shares for fiscal year 2025.
KESTRA MEDICAL TECHNOLOGIES, LTD. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 51.35M | +48430.0% |
| 2024 | 105,808 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | 58.35M | +58348953.0% | +13.4% |
| October 31, 2025 | 51.45M | — | +0.2% |
| July 31, 2025 | 51.35M | — | +0.0% |
| April 30, 2025 | 51.35M | +51348556.0% | +51348556.0% |
| January 31, 2025 | 100 | — | +0.0% |
| April 30, 2024 | 100 | — | — |
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed an increase of +48430.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, KESTRA MEDICAL TECHNOLOGIES, LTD.’s shares outstanding has grown by 48430.0% (from 105.8 thousand shares to 51.35 million shares).
- The most recent figure is from KESTRA MEDICAL TECHNOLOGIES, LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: